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Bio-Medical
A mobile pill transmitter system moves
through, or adjacent to, one or more or-
gans in an animal or human body, while
transmitting signals from its present loca-
tion and/or present angular orientation.
The system also provides signals from
which the present roll angle of the pill,
about a selected axis, can be determined.
When the location coordinates angular
orientation and the roll angle of the pill
are within selected ranges, an aperture
on the pill container releases a selected
chemical into, or onto, the body. Option-
ally, the pill, as it moves, provides a se-
quence of visually perceptible images.
The times for image formation may cor-
respond to times at which the pill trans-
mitter system location or image satisfies
one of at least four criteria. 
This invention provides and supplies
an algorithm for exact determination of
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System is part of targeted drug delivery. 
Ames Research Center, Moffett Field, California 
Dramatic improvements have been
made in NASA’s Whole Blood Staining
Device (WBSD) since it was last described
in “Whole-Blood-Staining Device,” NASA
Tech Briefs, Vol. 23, No. 10 (October
1999), page 64. The new system has a
longer shelf life, a simpler and more ef-
fective operational procedure, improved
interface with instrumentation, and
shorter processing time. More specifi-
cally, the improvements have targeted
bag and locking clip materials, sampling
ports, and air pocket prevention.
The WBSD stains whole blood col-
lected during spaceflight for subsequent
flow cytometric analysis. In short, the
main device stains white blood cells by
use of monoclonal antibodies conjugated
to various fluorochromes, followed by
lysing and fixing of the cells by use of a
commercial reagent that has been di-
luted according to NASA safety stan-
dards. This system is compact, robust,
and does not require electric power, pre-
cise mixing, or precise incubation times.
Figure 1 depicts the present improved
version for staining applications, which
is a poly(tetrafluoroethylene) bag with a
Luer-lock port and plastic locking clips.
An InterLink® (or equivalent) intra-
venous-injection port screws into the
Luer-lock port. The inflatable/collapsi-
ble nature of the bag facilitates loading
and helps to minimize the amount of air
trapped in the fully loaded bag.
Some additional uses have been iden-
tified for the device beyond whole blood
staining. The WBSD has been config-
ured for functional assays that require
culture of live cells by housing sterile
culture media, mitogens, and fixatives
prior to use [Figure 2(a)]. Simple injec-
tion of whole blood allows cell-stimula-
tion culture to be performed in reduced
gravity conditions, and product stabiliza-
tion prior to storage, while protecting as-
tronauts from liquid biohazardous mate-
rials. Also, the improved WBSD has
reconstituted powdered injectable an-
tibiotics by mixing them with diluent liq-
uids [Figure 2(b)]. Although such mix-
ing can readily be performed on Earth
by shaking in glass vials, it cannot readily
be performed this way in outer space
without entraining air bubbles. The
present device can be preloaded with
the powder and diluent(s) in separate
compartments. The powder and dilu-
ent(s) can be mixed, without introduc-
ing air bubbles, by removing the clip(s),
then shaking. This use of the device
could also be advantageous in terrestrial
applications because it maintains the iso-
lation of the constituents until the time
of use.
This work was done by Clarence F. Sams of
Johnson Space Center and Brian Crucian, Bon-
nie Paul, Shannon Melton, and Terry Guess of
Wyle Laboratories. Further information is con-
tained in a TSP (see page 1). MSC-24176-
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Figure 1. Photo of the Improved Version for
staining applications.
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Additional applications have been identified.
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Figure 2. WBSD Configurations: (a) for func-
tional assays, and (b) for powdered injectable
antibiotics.
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location coordinates and angular orien-
tation coordinates for a mobile pill
transmitter (PT), or other similar device
that is introduced into, and moves
within, a GI tract of a human or animal
body. A set of as many as eight nonlinear
equations has been developed and ap-
plied, relating propagation of a wireless
signal between either two, three, or
more transmitting antennas located on
the PT, to four or more non-coplanar re-
ceiving antennas located on a signal re-
ceiver appliance worn by the user. 
The equations are solved exactly,
without approximations or iterations,
and are applied in several environ-
ments: (1) association of a visual image,
transmitted by the PT at each of a sec-
ond sequence of times, with a PT loca-
tion and PT angular orientation at that
time; (2) determination of a position
within the body at which a drug or
chemical substance or other treatment
is to be delivered to a selected portion
of the body; (3) monitoring, after deliv-
ery, of the effect(s) of administration of
the treatment; and (4) determination of
one or more positions within the body
where provision and examination of a
finer-scale image is warranted. 
This work was done by John F. Schipper for
Ames Research Center. Further information is
contained in a TSP (see page 1). ARC-15810-1
Molecular Technique to Reduce PCR Bias for Deeper
Understanding of Microbial Diversity 
This technique has applications in medical manufacturing, food processing, and municipal
water treatment. 
NASA’s Jet Propulsion Laboratory, Pasadena, California
Current planetary protection policies
require that spacecraft targeted to sensi-
tive solar system bodies be assembled
and readied for launch in controlled
cleanroom environments. A better un-
derstanding of the distribution and fre-
quency at which high-risk contaminant
microbes are encountered on spacecraft
surfaces would significantly aid in assess-
ing the threat of forward contamination.
However, despite a growing understand-
ing of the diverse microbial populations
present in cleanrooms, less abundant
microbial populations are probably not
adequately taken into account due to
technological limitations. This novel ap-
proach encompasses a wide spectrum of
microbial species and will represent the
true picture of spacecraft cleanroom-as-
sociated microbial diversity. 
All of the current microbial diversity
assessment techniques are based on an
initial PCR amplification step. However,
a number of factors are known to bias
PCR amplification and jeopardize the
true representation of bacterial diversity.
PCR amplification of a minor template
appears to be suppressed by the amplifi-
cation of a more abundant template. It
is widely acknowledged among environ-
mental molecular microbiologists that
genetic biosignatures identified from an
environment only represent the most
dominant populations. The technologi-
cal bottleneck overlooks the presence of
the less abundant minority population
and may underestimate their role in the
ecosystem maintenance. 
DNA intercalating agents such as pro-
pidium monoazide (PMA) covalently
bind with DNA molecules upon photoly-
sis using visible light, and make it un-
available for DNA polymerase enzyme
during polymerase chain reaction
(PCR). Environmental DNA samples will
be treated with suboptimum PMA con-
centration, enough to intercalate with
90–99% of the total DNA. The probabil-
ity of PMA binding with DNA from
abundant bacterial species will be much
higher than binding with DNA from less
abundant species. This will increase the
relative DNA concentration of previ-
ously “shadowed” less abundant species
available for PCR amplification. These
PCR products obtained with and without
PMA treatment will then be subjected to
downstream diversity analyses such as se-
quencing and DNA microarray. It is ex-
pected that PMA-coupled PCR will am-
plify the “minority population” and help
in understanding microbial diversity
spectrum of an environmental sample at
a much deeper level. 
This new protocol aims to overcome
the major potential biases faced when
analyzing microbial 16S rRNA gene di-
versity. This study will lead to a techno-
logical advancement and a commercial
product that will aid microbial ecolo-
gists in understanding microbial diver-
sity from various environmental niches.
Implementation of this technique may
lead to discoveries of novel microbes
and their functions in sustenance of
the ecosystem. 
This work was done by Parag A. Vaisham-
payan and Kasthuri J. Venkateswaran of Cal-
tech for NASA’s Jet Propulsion Lab oratory. Fur-
ther information is contained in a TSP (see
page 1). NPO-48200
